Effects of folic acid supplementation on homocysteine level as primary prevention of heart disease

a systematic review

Mohd Ihsani Mahmood, Norazman Mohd Rosli, Muhammad Faizan A Shukor, Azmawati Mohammed Nawi, Norfazilah Ahmad, Shamsul Azhar Shah

Research output: Contribution to journalArticle

Abstract

Purpose: Supplements are commonly used to prevent cardiovascular diseases. Unfortunately, studies on folic acid supplementation have failed to support its benefit with pre-existing cardiovascular disease. Observational data suggest the benefit may be greater for healthy and at-risk individuals, but clinical trials have yet to be presented. The purpose of this paper is to systematically review evidence regarding the effectiveness of folic acid supplementation on homocysteine levels among healthy people who are at risk regarding the primary prevention of heart disease. Methods: PubMed, Science Direct, COCHRANE Library, and Clinical Trial.gov were searched from the year 2000 to 2015, with manual searches of references list and gray literature. Two investigators were selected to review fair- and good-quality trials that included healthy participants or healthy with risk, measurements of homocysteine levels and trials reporting at least one of the coronary heart diseases as an outcome. Dual quality assessments and data abstraction protocols were established. Results: There are limited new trials that have been published to show the effectiveness in primary prevention of cardiovascular disease. This limited evidence has given a strong association regarding the effects of folic acid supplementation in reducing homocysteine levels. However, the effectiveness for its role in the primary prevention of a cardiovascular event is still not proven as being beneficial. Conclusion: Limited evidence supports any benefit from folic acid supplementation for the primary prevention of coronary heart disease. Studies of the combined effect of folic acid with another preventative method of cardiovascular disease will help determine if folic acid supplementation causally reduces the cardiovascular event from the primary level. To prove its effectiveness, future clinical trials need to be performed.

Original languageEnglish
Pages (from-to)387-394
Number of pages8
JournalJournal of Public Health (Germany)
Volume23
Issue number6
DOIs
Publication statusPublished - 1 Dec 2015

Fingerprint

Homocysteine
Primary Prevention
Folic Acid
Heart Diseases
Cardiovascular Diseases
Clinical Trials
Coronary Disease
Preexisting Condition Coverage
PubMed
Libraries
Healthy Volunteers
Research Personnel

Keywords

  • Folic acid supplementation
  • Heart disease
  • Primary prevention
  • Systematic review

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health

Cite this

Effects of folic acid supplementation on homocysteine level as primary prevention of heart disease : a systematic review. / Mahmood, Mohd Ihsani; Rosli, Norazman Mohd; Shukor, Muhammad Faizan A; Mohammed Nawi, Azmawati; Ahmad, Norfazilah; Shah, Shamsul Azhar.

In: Journal of Public Health (Germany), Vol. 23, No. 6, 01.12.2015, p. 387-394.

Research output: Contribution to journalArticle

@article{26374b38853a43c1becd0a4b1be3b172,
title = "Effects of folic acid supplementation on homocysteine level as primary prevention of heart disease: a systematic review",
abstract = "Purpose: Supplements are commonly used to prevent cardiovascular diseases. Unfortunately, studies on folic acid supplementation have failed to support its benefit with pre-existing cardiovascular disease. Observational data suggest the benefit may be greater for healthy and at-risk individuals, but clinical trials have yet to be presented. The purpose of this paper is to systematically review evidence regarding the effectiveness of folic acid supplementation on homocysteine levels among healthy people who are at risk regarding the primary prevention of heart disease. Methods: PubMed, Science Direct, COCHRANE Library, and Clinical Trial.gov were searched from the year 2000 to 2015, with manual searches of references list and gray literature. Two investigators were selected to review fair- and good-quality trials that included healthy participants or healthy with risk, measurements of homocysteine levels and trials reporting at least one of the coronary heart diseases as an outcome. Dual quality assessments and data abstraction protocols were established. Results: There are limited new trials that have been published to show the effectiveness in primary prevention of cardiovascular disease. This limited evidence has given a strong association regarding the effects of folic acid supplementation in reducing homocysteine levels. However, the effectiveness for its role in the primary prevention of a cardiovascular event is still not proven as being beneficial. Conclusion: Limited evidence supports any benefit from folic acid supplementation for the primary prevention of coronary heart disease. Studies of the combined effect of folic acid with another preventative method of cardiovascular disease will help determine if folic acid supplementation causally reduces the cardiovascular event from the primary level. To prove its effectiveness, future clinical trials need to be performed.",
keywords = "Folic acid supplementation, Heart disease, Primary prevention, Systematic review",
author = "Mahmood, {Mohd Ihsani} and Rosli, {Norazman Mohd} and Shukor, {Muhammad Faizan A} and {Mohammed Nawi}, Azmawati and Norfazilah Ahmad and Shah, {Shamsul Azhar}",
year = "2015",
month = "12",
day = "1",
doi = "10.1007/s10389-015-0691-6",
language = "English",
volume = "23",
pages = "387--394",
journal = "Zeitschrift fur Gesundheitswissenschaften",
issn = "0943-1853",
publisher = "Springer Verlag",
number = "6",

}

TY - JOUR

T1 - Effects of folic acid supplementation on homocysteine level as primary prevention of heart disease

T2 - a systematic review

AU - Mahmood, Mohd Ihsani

AU - Rosli, Norazman Mohd

AU - Shukor, Muhammad Faizan A

AU - Mohammed Nawi, Azmawati

AU - Ahmad, Norfazilah

AU - Shah, Shamsul Azhar

PY - 2015/12/1

Y1 - 2015/12/1

N2 - Purpose: Supplements are commonly used to prevent cardiovascular diseases. Unfortunately, studies on folic acid supplementation have failed to support its benefit with pre-existing cardiovascular disease. Observational data suggest the benefit may be greater for healthy and at-risk individuals, but clinical trials have yet to be presented. The purpose of this paper is to systematically review evidence regarding the effectiveness of folic acid supplementation on homocysteine levels among healthy people who are at risk regarding the primary prevention of heart disease. Methods: PubMed, Science Direct, COCHRANE Library, and Clinical Trial.gov were searched from the year 2000 to 2015, with manual searches of references list and gray literature. Two investigators were selected to review fair- and good-quality trials that included healthy participants or healthy with risk, measurements of homocysteine levels and trials reporting at least one of the coronary heart diseases as an outcome. Dual quality assessments and data abstraction protocols were established. Results: There are limited new trials that have been published to show the effectiveness in primary prevention of cardiovascular disease. This limited evidence has given a strong association regarding the effects of folic acid supplementation in reducing homocysteine levels. However, the effectiveness for its role in the primary prevention of a cardiovascular event is still not proven as being beneficial. Conclusion: Limited evidence supports any benefit from folic acid supplementation for the primary prevention of coronary heart disease. Studies of the combined effect of folic acid with another preventative method of cardiovascular disease will help determine if folic acid supplementation causally reduces the cardiovascular event from the primary level. To prove its effectiveness, future clinical trials need to be performed.

AB - Purpose: Supplements are commonly used to prevent cardiovascular diseases. Unfortunately, studies on folic acid supplementation have failed to support its benefit with pre-existing cardiovascular disease. Observational data suggest the benefit may be greater for healthy and at-risk individuals, but clinical trials have yet to be presented. The purpose of this paper is to systematically review evidence regarding the effectiveness of folic acid supplementation on homocysteine levels among healthy people who are at risk regarding the primary prevention of heart disease. Methods: PubMed, Science Direct, COCHRANE Library, and Clinical Trial.gov were searched from the year 2000 to 2015, with manual searches of references list and gray literature. Two investigators were selected to review fair- and good-quality trials that included healthy participants or healthy with risk, measurements of homocysteine levels and trials reporting at least one of the coronary heart diseases as an outcome. Dual quality assessments and data abstraction protocols were established. Results: There are limited new trials that have been published to show the effectiveness in primary prevention of cardiovascular disease. This limited evidence has given a strong association regarding the effects of folic acid supplementation in reducing homocysteine levels. However, the effectiveness for its role in the primary prevention of a cardiovascular event is still not proven as being beneficial. Conclusion: Limited evidence supports any benefit from folic acid supplementation for the primary prevention of coronary heart disease. Studies of the combined effect of folic acid with another preventative method of cardiovascular disease will help determine if folic acid supplementation causally reduces the cardiovascular event from the primary level. To prove its effectiveness, future clinical trials need to be performed.

KW - Folic acid supplementation

KW - Heart disease

KW - Primary prevention

KW - Systematic review

UR - http://www.scopus.com/inward/record.url?scp=84958770355&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84958770355&partnerID=8YFLogxK

U2 - 10.1007/s10389-015-0691-6

DO - 10.1007/s10389-015-0691-6

M3 - Article

VL - 23

SP - 387

EP - 394

JO - Zeitschrift fur Gesundheitswissenschaften

JF - Zeitschrift fur Gesundheitswissenschaften

SN - 0943-1853

IS - 6

ER -